Quality Of Life Sustainability Report

Overview

The report describes Helsinn's 2024 Group-wide sustainability performance across its pharmaceutical operations. It highlights the first Group-wide Decarbonization Plan, a Net Zero 2050 roadmap, and the fifth consecutive year of maintained carbon neutrality. The report also records 282 employees and detailed energy, water, waste, and GHG disclosures, including 1,465 tCO2e of Scope 1 emissions and 10,252 tons CO2e of Scope 3 emissions. Governance is led by the Board of Directors, supported by a Group sustainability and ESG function.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview